Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

Podcast

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.

In this episode of the Endocrine Outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of a recent study he led examining the effects of metabolic syndrome on outcomes in patients with coronavirus disease 2019 (COVID-19) in a predominantly Black population.

Results of the study suggest individual components on metabolic syndrome were not associated with worse outcomes but their combined presence in the form of metabolic syndrome resulted in more severe outcomes among their patient population.

Related Videos
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
© 2024 MJH Life Sciences

All rights reserved.